You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: RE39680


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE39680
Title:Substituted heterocycle fused gamma-carbolines
Abstract: The present invention is directed to certain novel compounds represented by structural Formula (I) ##STR00001## or pharmaceutically acceptable salt forms thereof, wherein R.sup.1, R.sup.5, R.sup.6a, R.sup.6b, R.sup.7, R.sup.8, R.sup.9, X, b, k, m, and n, and the dashed lines are described herein. The invention is also concerned with pharmaceutical formulations comprising these novel compounds as active ingredients and the use of the novel compounds and their formulations in the treatment of certain disorders. The compounds of this invention are serotonin agonists and antagonists and are useful in the control or prevention of central nervous system disorders including obesity, anxiety, depression, psychosis, schizophrenia, sleep disorders, sexual disorders, migraine, conditions associated with cephalic pain, social phobias, and gastrointestinal disorders such as dysfunction of the gastrointestinal tract motility.
Inventor(s): Robichaud; Albert J. (Landenberg, PA), Lee; Taekyu (Wilmington, DE), Deng; Wei (Wilmington, DE), Mitchell; Ian S. (Philadelphia, PA), Yang; Michael Guang (Wilmington, DE), Haydar; Simon (Niskayuna, NY), Chen; Wenting (Exton, PA), McClung; Christopher D. (Wilmington, DE), Calvello; Emile J. B. (Bryn Mawr, PA), Zawrotny; David M. (Moorestown, NJ), Rajagopalan; Parthasarathl (Chennai, IN)
Assignee: Bristol-Myers Squibb Pharma Company (Princeton, NJ)
Application Number:11/356,421
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

When analyzing the scope and claims of a U.S. patent, it is crucial to delve into the intricacies of patent law, the process of patent application and granting, and the implications of patent claims on innovation and litigation. This article will provide a comprehensive overview of the patent landscape, focusing on key aspects such as patent scope, claim construction, and the legal framework surrounding U.S. patents.

What are Patents and How Are They Granted?

Patents are intellectual property rights granted to inventors by the United States Patent and Trademark Office (USPTO) for their inventions. The USPTO issues various types of patents, including utility patents, plant patents, design patents, and trademarks[1].

The Role of the USPTO

The USPTO is responsible for handling patent and trademark applications and issuing registrations. The process involves a thorough examination to ensure that the invention meets the criteria of novelty, non-obviousness, and usefulness. Patents protect inventions in the U.S. market, and the data from these patents can be analyzed to understand trends and patterns in innovation[1].

Patent Scope and Claims

Metrics for Measuring Patent Scope

Patent scope is a critical aspect of patent quality debates. Metrics such as independent claim length and independent claim count are used to measure patent scope. These metrics have explanatory power for various correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Claim Construction

Claim construction is the process of interpreting the language of patent claims to determine their scope. This process is crucial in patent litigation, as it defines what the patent covers and what constitutes infringement. Claims must be given the meaning that the relevant artisan would understand, taking into account the specification and the prosecution history of the patent[2].

International Patent Classification and Fractional Counting

Patents are classified under the International Patent Classification (IPC) system, which helps in categorizing inventions into specific technology areas. The use of fractional counting avoids double counting across sectors and technology areas, ensuring that each country or sector receives appropriate credit for the invention based on the residences of the inventors[1].

Patent Infringement and Litigation

Case Studies

  • Lite-Netics LLC v. Nu Tsai Capital LLC: This case highlights the complexities of claim construction and infringement allegations. The court ruled that Lite-Netics’s allegations of direct infringement were not objectively baseless, emphasizing the importance of reasonable interpretations of claim language[2].
  • Amgen Inc. v. Sanofi: This Supreme Court case involved patents covering antibodies and the enablement requirement. The court deliberated on whether Amgen’s patents met the requirement to enable any person skilled in the art to make and use the invention, underscoring the need for clear and concise descriptions in patent claims[5].

The Impact of Patent Scope on Innovation

Broad vs. Narrow Claims

The scope of patent claims can significantly impact innovation. Broader claims may lead to increased licensing and litigation costs, potentially diminishing incentives for innovation. Conversely, narrower claims are associated with a higher probability of grant and a shorter examination process, facilitating smoother innovation pathways[3].

Real-World Applications: Pearl’s Dental AI Patents

Example of AI Technology Patents

Pearl, a leader in dental AI solutions, has been granted several U.S. patents for its machine learning techniques used in dental practice data analysis. These patents cover computer vision-based analysis of provider data, identifying missed treatment opportunities, and synthesizing findings into actionable insights. This example illustrates how patents can protect and enhance technological advancements in specific industries[4].

Legal Framework and Enablement Requirement

The enablement requirement, as outlined in 35 U.S.C. §112(a), mandates that a patent applicant describe the invention in such full, clear, concise, and exact terms as to enable any person skilled in the art to make and use the invention. This requirement is crucial in ensuring that patents are valid and do not claim overly broad or vague inventions[5].

Geographic Allocation of Patents

Patents are allocated to countries based on the residences of inventors, using fractional counting to avoid double counting. This method ensures that credit is allocated accurately, even in cases where multiple countries are involved in the invention process[1].

Key Takeaways

  • Patent Scope and Claims: The scope of a patent is critical and can be measured using metrics like independent claim length and count.
  • Claim Construction: Interpretation of claim language is essential in determining patent scope and resolving infringement disputes.
  • International Classification: Patents are classified under the IPC system, and fractional counting is used to allocate credit to different countries.
  • Innovation Impact: The breadth of patent claims can influence innovation by affecting licensing and litigation costs.
  • Legal Framework: The enablement requirement ensures that patents are clear and enable skilled artisans to make and use the invention.

FAQs

  1. What is the role of the USPTO in the patent process? The USPTO is responsible for handling patent and trademark applications and issuing registrations, ensuring that inventions meet the criteria of novelty, non-obviousness, and usefulness.

  2. How is patent scope measured? Patent scope can be measured using metrics such as independent claim length and independent claim count, which have explanatory power for various correlates of patent scope.

  3. What is the significance of claim construction in patent litigation? Claim construction is crucial in determining the scope of a patent and resolving infringement disputes, as it defines what the patent covers and what constitutes infringement.

  4. How are patents allocated to countries? Patents are allocated to countries based on the residences of inventors, using fractional counting to avoid double counting across sectors and technology areas.

  5. What is the enablement requirement in patent law? The enablement requirement mandates that a patent applicant describe the invention in such full, clear, concise, and exact terms as to enable any person skilled in the art to make and use the invention.

Sources

  1. National Science Foundation. Invention, Knowledge Transfer, and Innovation. 2024.
  2. United States Court of Appeals for the Federal Circuit. Lite-Netics LLC v. Nu Tsai Capital LLC. 2023.
  3. SSRN. Patent Claims and Patent Scope. 2016.
  4. HelloPearl. Pearl Granted U.S. Patent for Dental Practice Data Analysis AI Technology. 2023.
  5. Supreme Court of the United States. Amgen Inc. v. Sanofi. 2023.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent RE39680

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent RE39680

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 024377 ⤷  Subscribe
Argentina 024378 ⤷  Subscribe
Argentina 024379 ⤷  Subscribe
Austria 277048 ⤷  Subscribe
Austria 277055 ⤷  Subscribe
Austria 277928 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.